A Phase 1 Study of JNJ-87890387 for Advanced Solid Tumors
87890387STM1001
Phase 1 other active
Quick answer
A Phase 1 Study of JNJ-87890387 for Advanced Solid Tumors for Advanced Solid Tumors is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active